Melinda Fischer
Family · Fredericktown, MONPI 1083782395
Payments from drug & device makers
Across 266 payments — averaging $18.09 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$2K
- Novo Nordisk$304
- Otsuka America Pharmaceutical, Inc.$239
- Biohaven Pharmaceuticals, Inc.$195
- Biohaven Pharmaceutical Holding Company Ltd.$166
- Astellas Pharma US Inc$156
- plus $2K from 32 others
What the payments were for
- Food & beverage$4,72798%
- Education$852%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 105 | $1,844 |
| Novo Nordisk | 16 | $304 |
| Otsuka America Pharmaceutical, Inc. | 13 | $239 |
| Biohaven Pharmaceuticals, Inc. | 8 | $195 |
| Biohaven Pharmaceutical Holding Company Ltd. | 7 | $166 |
| Astellas Pharma US Inc | 6 | $156 |
| Lilly USA, LLC | 8 | $129 |
| Johnson & Johnson | 11 | $129 |
| AstraZeneca | 8 | $118 |
| Abbott | 4 | $113 |
| Merck | 6 | $106 |
| GSK | 7 | $101 |
| Novartis | 6 | $100 |
| Grifols USA, LLC | 5 | $95 |
| Axsome Therapeutics, Inc. | 5 | $94 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 4 | $89 |
| Vanda Pharmaceuticals Inc. | 4 | $85 |
| Boehringer Ingelheim | 4 | $77 |
| Lundbeck LLC | 4 | $73 |
| Pfizer | 4 | $68 |
| Nestle Healthcare Nutrition Inc. | 4 | $63 |
| Supernus Pharmaceuticals, Inc. | 3 | $58 |
| Endo Pharmaceuticals Inc. | 3 | $53 |
| Aimmune Therapeutics, Inc. | 2 | $45 |
| Amgen | 2 | $43 |
| Bayer | 2 | $38 |
| Sumitomo Pharma America, Inc. | 2 | $33 |
| Clarus Therapeutics Inc. | 2 | $30 |
| Sunovion Pharmaceuticals Inc. | 2 | $26 |
| Amarin Pharma, Inc. | 1 | $24 |
| Daiichi Sankyo Inc. | 1 | $20 |
| Eisai Inc. | 1 | $19 |
| Dexcom, Inc. | 1 | $16 |
| Gilead | 1 | $16 |
| Idorsia Pharmaceuticals US Inc | 1 | $14 |
| Kyowa Kirin, Inc. | 1 | $14 |
| E.r. Squibb & Sons, L.L.C. | 1 | $12 |
| Organon | 1 | $6 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- NURTEC ODT$101
How this compares
$4,812 in reported general payments places this provider in the 90th percentile of 3,812 family providers in Missouri.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 15 | $17,661 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 27 | $17,162 |
| Anoro ElliptaUmeclidinium Brm/Vilanterol Tr | 23 | $15,022 |
| MounjaroTirzepatide | 15 | $14,478 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 11 | $6,588 |
| Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog | 15 | $6,420 |
| LinzessLinaclotide | 12 | $6,378 |
| Dexlansoprazole DrDexlansoprazole | 13 | $3,010 |
| Potassium Chloride | 123 | $2,305 |
| Desvenlafaxine Succinate ErDesvenlafaxine Succinate | 41 | $1,654 |
| Omeprazole | 122 | $1,470 |
| Esomeprazole Magnesium | 34 | $1,322 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 48 | $1,263 |
| Comfort Ez Pen NeedlePen Needle, Diabetic | 13 | $1,195 |
| Levothyroxine Sodium | 138 | $1,053 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| GSKAnoro Ellipta, Trelegy Ellipta | $101 | $21,61034 claims |
| Novo NordiskOzempic | $304 | $17,66115 claims |
| AstraZenecaBreztri Aerosphere | $118 | $17,16227 claims |
| Lilly USA, LLCMounjaro | $129 | $14,47815 claims |
| AbbVieLinzess, Synthroid | $1,844 | $7,32430 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 3,812 family providers in Missouri.
Other family in Fredericktown
- Connie SpencerSaint Joseph$320K
- Shayla SandersKansas City$306K
- Tamera WolfLees Summit$215K
- Tiffany ArnoldFestus$177K
- Tiffany NelsonSedalia$164K
- Chelsey BeckerSaint Peters$104K
- Carey PattonDes Peres$94K
- Marcy MarkesColumbia$92K
- Laura HedigerSpringfield$71K
- Rebecca SeabaughSaint Louis$68K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.